Colette Smit

Summary

Affiliation: Municipal Health Service
Country: The Netherlands

Publications

  1. ncbi Highly active antiretroviral therapy (HAART) among HIV-infected drug users: a prospective cohort study of sexual risk and injecting behaviour
    Colette Smit
    Health Service, Amsterdam, The Netherlands
    Addiction 101:433-40. 2006
  2. ncbi Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion
    Colette Smit
    Municipal Health Service, Amsterdam, The Netherlands
    AIDS 20:741-9. 2006
  3. doi Episodes of HIV viremia and the risk of non-AIDS diseases in patients on suppressive antiretroviral therapy
    Shuangjie Zhang
    Stichting HIV monitoring, Amsterdam, The Netherlands
    J Acquir Immune Defic Syndr 60:265-72. 2012
  4. doi Clinical significance of transient HIV type-1 viraemia and treatment interruptions during suppressive antiretroviral treatment
    Shuangjie Zhang
    Stichting HIV monitoring, Amsterdam, The Netherlands
    Antivir Ther 15:555-62. 2010
  5. doi Risk of hepatitis-related mortality increased among hepatitis C virus/HIV-coinfected drug users compared with drug users infected only with hepatitis C virus: a 20-year prospective study
    Colette Smit
    Cluster Infectious Diseases, Health Service of Amsterdam, Amsterdam, AZ, The Netherlands
    J Acquir Immune Defic Syndr 47:221-5. 2008
  6. doi Immune restoration and onset of new AIDS-defining events with combination antiretroviral therapy in HIV type-1-infected immigrants in the Netherlands
    Anouk M Kesselring
    HIV Monitoring Foundation, Amsterdam, The Netherlands
    Antivir Ther 15:871-9. 2010
  7. ncbi Declining AIDS mortality in Amsterdam: contributions of declining HIV incidence and effective therapy
    Colette Smit
    Municipal Health Service, Amsterdam, The Netherlands
    Epidemiology 15:536-42. 2004
  8. pmc Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users
    Charlotte Van Den Berg
    Department of Human Retrovirology, Center for Infection and Immunity Amsterdam, Academic Medical Center, Amsterdam, The Netherlands
    Addiction 102:1454-62. 2007
  9. doi Immunodeficiency as a risk factor for non-AIDS-defining malignancies in HIV-1-infected patients receiving combination antiretroviral therapy
    Anouk Kesselring
    HIV Monitoring Foundation, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Clin Infect Dis 52:1458-65. 2011
  10. doi Self-reported symptoms among HIV-lnfected patients on highly active antiretroviral therapy in the ATHENA cohort in The Netherlands
    I Marion de Boer
    Department of Medical Psychology, Academic Medical Centre, Amsterdam, The Netherlands
    HIV Clin Trials 12:161-70. 2011

Collaborators

Detail Information

Publications20

  1. ncbi Highly active antiretroviral therapy (HAART) among HIV-infected drug users: a prospective cohort study of sexual risk and injecting behaviour
    Colette Smit
    Health Service, Amsterdam, The Netherlands
    Addiction 101:433-40. 2006
    ..To study sexual risk and injecting behaviour among HIV-infected drug users (DU) receiving highly active antiretroviral therapy (HAART)...
  2. ncbi Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion
    Colette Smit
    Municipal Health Service, Amsterdam, The Netherlands
    AIDS 20:741-9. 2006
    ..Although HAART has led to a reduction in overall mortality among HIV-infected individuals, its impact on death from specific causes is unknown...
  3. doi Episodes of HIV viremia and the risk of non-AIDS diseases in patients on suppressive antiretroviral therapy
    Shuangjie Zhang
    Stichting HIV monitoring, Amsterdam, The Netherlands
    J Acquir Immune Defic Syndr 60:265-72. 2012
    ..We investigated whether nonstructured treatment interruptions and episodes of viremia during suppressive combination antiretroviral therapy were independently associated with non-AIDS diseases...
  4. doi Clinical significance of transient HIV type-1 viraemia and treatment interruptions during suppressive antiretroviral treatment
    Shuangjie Zhang
    Stichting HIV monitoring, Amsterdam, The Netherlands
    Antivir Ther 15:555-62. 2010
    ..We studied the effect of such episodes and of treatment interruptions on clinical outcome and immunological response...
  5. doi Risk of hepatitis-related mortality increased among hepatitis C virus/HIV-coinfected drug users compared with drug users infected only with hepatitis C virus: a 20-year prospective study
    Colette Smit
    Cluster Infectious Diseases, Health Service of Amsterdam, Amsterdam, AZ, The Netherlands
    J Acquir Immune Defic Syndr 47:221-5. 2008
    ..To disentangle the effects of HCV and HIV, we compared the overall and cause-specific mortality between HCV/HIV-infected DUs and HCV-infected DUs and DUs without HCV or HIV, followed up between 1985 and 2006...
  6. doi Immune restoration and onset of new AIDS-defining events with combination antiretroviral therapy in HIV type-1-infected immigrants in the Netherlands
    Anouk M Kesselring
    HIV Monitoring Foundation, Amsterdam, The Netherlands
    Antivir Ther 15:871-9. 2010
    ..We investigated differences in immune restoration and onset of new AIDS-defining events on combination antiretroviral therapy (cART) among HIV type-1 (HIV-1)-infected patients of different regional origin now living in the Netherlands...
  7. ncbi Declining AIDS mortality in Amsterdam: contributions of declining HIV incidence and effective therapy
    Colette Smit
    Municipal Health Service, Amsterdam, The Netherlands
    Epidemiology 15:536-42. 2004
    ..We aimed to evaluate the impact of highly active antiretroviral therapy (HAART) on AIDS mortality, taking into account earlier HIV incidence patterns...
  8. pmc Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users
    Charlotte Van Den Berg
    Department of Human Retrovirology, Center for Infection and Immunity Amsterdam, Academic Medical Center, Amsterdam, The Netherlands
    Addiction 102:1454-62. 2007
    ..To investigate the impact of harm-reduction programmes on HIV and hepatitis C virus (HCV) incidence among ever-injecting drug users (DU) from the Amsterdam Cohort Studies (ACS)...
  9. doi Immunodeficiency as a risk factor for non-AIDS-defining malignancies in HIV-1-infected patients receiving combination antiretroviral therapy
    Anouk Kesselring
    HIV Monitoring Foundation, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Clin Infect Dis 52:1458-65. 2011
    ..The aim of this study was to investigate the association between immunodeficiency, viremia, and non-AIDS-defining malignancies (NADM)...
  10. doi Self-reported symptoms among HIV-lnfected patients on highly active antiretroviral therapy in the ATHENA cohort in The Netherlands
    I Marion de Boer
    Department of Medical Psychology, Academic Medical Centre, Amsterdam, The Netherlands
    HIV Clin Trials 12:161-70. 2011
    ..1 years. Additionally, we studied whether self-reported symptoms were related to concurrent quality of life and virological failure...
  11. pmc Rise in seroprevalence of herpes simplex virus type 1 among highly sexual active homosexual men and an increasing association between herpes simplex virus type 2 and HIV over time (1984-2003)
    Colette Smit
    Cluster Infectious Diseases, Health Service of Amsterdam, Stichting HIV monitoring, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands
    Eur J Epidemiol 22:937-44. 2007
    ..HSV-2 is considered to be an important risk factor for HIV transmission. We therefore studied changes in the HSV-1 and HSV-2 prevalence in a large cohort of men who have sex with men (MSM) over a 20-year time period...
  12. pmc Late entry to HIV care limits the impact of anti-retroviral therapy in The Netherlands
    Colette Smit
    HIV Monitoring Foundation Amsterdam, Amsterdam, The Netherlands
    PLoS ONE 3:e1949. 2008
    ..To explain differences in survival in the first three years of combination anti-retroviral therapy (cART) between HIV treatment centres in The Netherlands...
  13. doi Health-related quality of life and survival among HIV-infected patients receiving highly active antiretroviral therapy: a study of patients in the AIDS Therapy Evaluation in the Netherlands (ATHENA) Cohort
    I Marion de Boer-van der Kolk
    Department of Medical Psychology, Tropical Medicine and AIDS, Department of Internal Medicine, Academic Medical Centre, Amsterdam, The Netherlands
    Clin Infect Dis 50:255-63. 2010
    ..This study investigates whether HRQL predicts survival among HIV-infected patients receiving HAART...
  14. ncbi Decline in HIV incidence and injecting, but not in sexual risk behaviour, seen in drug users in Amsterdam: a 19-year prospective cohort study
    Catharina E A Lindenburg
    Health Service of Amsterdam, Cluster Infectious Diseases, Department of Research, 1000 CE Amsterdam, The Netherlands
    AIDS 20:1771-5. 2006
    ..Initiated in 1985, the ACS enables us to study changes in trends since HAART became widespread in 1996...
  15. doi The comparison of the performance of two screening strategies identifying newly-diagnosed HIV during pregnancy
    Kees Boer
    Department of Obstetrics, Academic Medical Centre, Amsterdam, The Netherlands
    Eur J Public Health 21:632-7. 2011
    ..In case of infection, screening was followed by prevention of mother-to-child-transmission (PMTCT). We compared the performance of the two strategies in terms of detection of new cases of HIV and vertical transmission...
  16. ncbi Could better tolerated HIV drug regimens improve patient outcome?
    Mikaela Smit
    Department of Infectious Disease Epidemiology, Imperial College, Faculty of Medicine, London, UK
    AIDS 26:1953-9. 2012
    ....
  17. pmc Measuring the Quality of Data Collection in a Large Observational Cohort of HIV and AIDS
    Mariska Hillebregt
    HIV Monitoring Foundation, Amsterdam, The Netherlands
    Open AIDS J 4:96-102. 2010
    ..Among physicians, there should be more agreement about what information to record in the charts, to facilitate data extraction for data collectors...
  18. ncbi Lymphogranuloma venereum proctitis in men who have sex with men is associated with anal enema use and high-risk behavior
    Henry J C de Vries
    STI Outpatient Clinic, Cluster Infectious Diseases, Public Health Service Amsterdam The Netherlands
    Sex Transm Dis 35:203-8. 2008
    ..In the industrialized world, lymphogranuloma venereum proctitis (LGVP) has been reported only in men who have sex with men. Factors responsible for the outbreak remain to be elucidated...
  19. pmc Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users
    Charlotte H S B van den Berg
    Department of Human Retrovirology, Academic Medical Center, and Health Service of Amsterdam, Nieuwe Achtergracht 100, 1018 WT Amsterdam, The Netherlands
    Eur J Epidemiol 22:183-93. 2007
    ..4 times the HIV incidence, a pattern seen over the entire study period. The simultaneous decline of both HCV and HIV incidence probably results from reduced risk behavior at the population level...
  20. ncbi Hospitalizations during a measles epidemic in the Netherlands, 1999 to 2000
    Susan van den Hof
    Department of Infectious Diseases Epidemiology, National Institute of Public Health and the Environment, Bilthoven, The Netherlands
    Pediatr Infect Dis J 21:1146-50. 2002
    ..A measles epidemic occurred in the Netherlands in 1999 to 2000. We collected data on hospitalized and deceased cases to inform the public about the risks associated with measles infection...